Cardiac resynchronisation therapy and the role of optimal device utilisation

S Buck; A H Maass; D J van Veldhuisen; I C Van Gelder

doi:10.1007/BF03086283

Cardiac resynchronisation therapy and the role of optimal device utilisation

Neth Heart J. 2009 Sep;17(9):354-7. doi: 10.1007/BF03086283.

Authors

S Buck¹, A H Maass, D J van Veldhuisen, I C Van Gelder

Affiliation

¹ Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Abstract

Despite established selection criteria, 30 to 40% of patients do not respond to cardiac resynchronisation therapy. By optimising programming of the device response to cardiac resynchronisation, therapy can be improved. (Neth Heart J 2009;17:354-7.).